Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease

Published:2020-08 Issue: Volume:178 Page:114103
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Lescoat Alain,Lelong Marie,Jeljeli Mohamed,Piquet-Pellorce Claire,Morzadec Claudie,Ballerie Alice,Jouneau Stéphane,Jego Patrick,Vernhet Laurent,Batteux Fréderic,Fardel Olivier,Lecureur Valérie

Funder

Institut National de la Santé et de la Recherche Médicale

Université de Rennes

Association des sclérodermiques de France

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference68 articles.

1. Translating JAKs to Jakinibs;Gadina;J Immunol.,2020

2. Janus kinases to jakinibs: from basic insights to clinical practice;Gadina;Rheumatology (Oxford).,2019

3. Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis;Verstovsek;N Engl J Med.,2010

4. Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis;Taylor;N Engl J Med.,2017

5. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis;Fleischmann;N Engl J Med,2012

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review;Autoimmunity Reviews;2024-10

2. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells;Frontiers in Immunology;2024-08-12

3. Nodular scleroderma partially controlled with tofacitinib;Anais Brasileiros de Dermatologia;2024-08

4. JAK Inhibitors in Rheumatoid Arthritis: Immunomodulatory Properties and Clinical Efficacy;International Journal of Molecular Sciences;2024-07-30

5. CD206⁺macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis;Thorax;2024-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3